STRODIGI

Welcome to the Brand page for “STRODIGI”, which is offered here for Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, lennox-gastaut syndrome (lgs), sclerosis, porphyria, huntington's disorder and disease, insomnia, parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, adhd, ptsd, agitation, aggression, autism, melancholy, ocd, tourette's syndrome, progressive supranuclear palsy (psp), restlessness, akathisia, fatigue, somnolence, nausea, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents for medical purposes;surgical and medical apparatus and instruments; devices, syringes and needles for injections and medical purposes; apparatus and instruments for diagnostic purposes including test kits; integrated medical systems containing medical instruments and software for information and information management for use of a web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments for information, guidance, management and control of medicines;.

Its status is currently believed to be active. Its class is unavailable. “STRODIGI” is believed to be currently owned by “H. Lundbeck A/S”.